These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32851933)

  • 1. Targeting homologous recombination (HR) repair mechanism for cancer treatment: discovery of new potential UCHL-3 inhibitors
    Alakhdar AA; Saleh AH; Arafa RK
    J Biomol Struct Dyn; 2022 Jan; 40(1):276-289. PubMed ID: 32851933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
    Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Search for potentially biased epidermal growth factor receptor (EGFR) inhibitors through pharmacophore modelling, molecular docking, and molecular dynamics (MD) simulation approaches.
    Jethwa M; Gangopadhyay A; Saha A
    J Biomol Struct Dyn; 2023 Mar; 41(5):1681-1689. PubMed ID: 35014597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of novel ligand targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery: complete pharmacophore approach.
    Shanmugam V; Muthukrishnan S
    J Biomol Struct Dyn; 2023; 41(23):14524-14539. PubMed ID: 36841551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential inhibitors for FKBP51: an
    Barge S; Jade D; Ayyamperumal S; Manna P; Borah J; Nanjan CMJ; Nanjan MJ; Talukdar NC
    J Biomol Struct Dyn; 2022; 40(24):13799-13811. PubMed ID: 34709133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies.
    Ekhteiari Salmas R; Unlu A; Bektaş M; Yurtsever M; Mestanoglu M; Durdagi S
    J Biomol Struct Dyn; 2017 Jul; 35(9):1899-1915. PubMed ID: 27315035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based pharmacophore modeling, virtual screening and simulation studies for the identification of potent anticancerous phytochemical lead targeting cyclin-dependent kinase 2.
    Sharma M; Sharma N; Muddassir M; Rahman QI; Dwivedi UN; Akhtar S
    J Biomol Struct Dyn; 2022; 40(20):9815-9832. PubMed ID: 34151738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel metallo-β-lactamases inhibitors using ligand-based pharmacophore modelling and structure-based virtual screening.
    Ezati M; Ahmadi A; Behmard E; Najafi A
    J Biomol Struct Dyn; 2024; 42(20):10672-10687. PubMed ID: 37732367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2.
    Yadav R; Imran M; Dhamija P; Chaurasia DK; Handu S
    J Biomol Struct Dyn; 2021 Oct; 39(17):6617-6632. PubMed ID: 32715956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of ligand and structure-based pharmacophore screening for the identification of novel natural leads against Euchromatic histone lysine methyltransferase 2 (EHMT2/G9a).
    Jana A; Naga R; Saha S; Griñán-Ferré C; Banerjee DR
    J Biomol Struct Dyn; 2024 Apr; 42(7):3535-3562. PubMed ID: 37216299
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Yang Y; Ji C; Zhong Q; Yan H; Wang J
    J Biomol Struct Dyn; 2024; 42(24):13372-13385. PubMed ID: 37904331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of potential inhibitors for stat3: ligand based 3D pharmacophore, virtual screening, molecular docking, dynamic studies and
    Lakshmanan K; T K P; K Pai SR; Rajagopal K; Byran G
    J Biomol Struct Dyn; 2022; 40(21):11320-11338. PubMed ID: 34463213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential target identification for breast cancer and screening of small molecule inhibitors: A bioinformatics approach.
    Agarwal S; Kashaw SK
    J Biomol Struct Dyn; 2021 Apr; 39(6):1975-1989. PubMed ID: 32186248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-based pharmacophore modeling of TNF-α to design novel inhibitors using virtual screening and molecular dynamics.
    Jade DD; Pandey R; Kumar R; Gupta D
    J Biomol Struct Dyn; 2022 Mar; 40(4):1702-1718. PubMed ID: 33034255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying potential inhibitors of C-X-C motif chemokine ligand10 against vitiligo: structure-based virtual screening, molecular dynamics simulation, and principal component analysis.
    Khan MKA; Alouffi S; Ahmad S
    J Biomol Struct Dyn; 2024 Sep; 42(15):8045-8062. PubMed ID: 37565326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of megacerotonic acid and a quinazoline derivative from Universal Natural Product Database as potential inhibitors of
    Adamu RM; Ibrahim B; Ibrahim MA; Balogun EO
    J Biomol Struct Dyn; 2023 Jan; 41(1):45-54. PubMed ID: 34812693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discover potential inhibitors for PFKFB3 using 3D-QSAR, virtual screening, molecular docking and molecular dynamics simulation.
    Bao Y; Zhou L; Dai D; Zhu X; Hu Y; Qiu Y
    J Recept Signal Transduct Res; 2018; 38(5-6):413-431. PubMed ID: 30822195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel inhibitors of S-adenosyl-L-homocysteine hydrolase via structure-based virtual screening and molecular dynamics simulations.
    Chen C; Zhou XH; Cheng W; Peng YF; Yu QM; Tan XD
    J Mol Model; 2022 Sep; 28(10):336. PubMed ID: 36180796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying natural product inhibitors against CDK9 enzyme via combined multicomplex-based pharmacophore modeling, interaction studies and molecular dynamics simulations.
    Ghosh A; Mukherjee S; Jha PC; Manhas A
    Comput Biol Med; 2023 Jul; 161():107055. PubMed ID: 37244149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of promising molecules against MurD ligase from Acinetobacter baumannii: insights from comparative protein modelling, virtual screening, molecular dynamics simulations and MM/PBSA analysis.
    Jha RK; Khan RJ; Amera GM; Singh E; Pathak A; Jain M; Muthukumaran J; Singh AK
    J Mol Model; 2020 Oct; 26(11):304. PubMed ID: 33068184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.